Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LIVEgg is an Israeli biotechnology company specializing in non-invasive, real-time embryo sexing for the poultry industry. The company has developed a proprietary sensing technology that identifies the sex of a chicken embryo through the eggshell during the early stages of incubation. This "in-ovo" sexing solution aims to eliminate the ethically problematic and economically wasteful practice of culling male chicks in the egg-laying industry. By providing a high-speed, automated alternative to manual sexing, LIVEgg enhances animal welfare and improves hatchery profitability. The technology is designed to be easily integrated into existing hatchery workflows without compromising hatchability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LIVEgg.